Biotech & Health
Williams··2 min read
Biotech’s Cross-Border Evolution: From GLP-1 Partnerships to Age-Reversal Research
The biotech industry is seeing increased cross-border collaboration, with progress in GLP-1 obesity treatments and innovations in cellular reprogramming and drug delivery driving global advancements in medical science.
